CN Patent

CN110575444A — 一种盐酸多塞平膜控释制剂的制备方法

Assigned to Suzhou Hong Sen Pharmaceutical Ltd By Share Ltd · Expires 2019-12-17 · 6y expired

What this patent protects

本发明属于药物制剂创新制剂技术领域,具体地,涉及一种盐酸多塞平膜控释制剂的制备方法,包括如下步骤:按处方量称取盐酸多塞平、二氧化硅、微晶纤维素乳糖复合物、喷雾干燥乳糖、微晶纤维素、硬脂酸镁,备用;置于万能粉碎机粉碎,然后加入多向混合机中混合;根据中间体的含量,计算片重,采用圆形浅凹模具压片;将片芯置于高效包衣锅中,开启包衣锅,控制包衣参数进行包衣,监测包衣增重,当包衣增重达到要求时,结束包衣,制得盐酸多塞平膜控释制剂。采用直压片工艺结合胃溶性膜衣,可以有效提高盐酸多塞平膜控释制剂的生物利用度和稳定性,且纯度更高。

USPTO Abstract

本发明属于药物制剂创新制剂技术领域,具体地,涉及一种盐酸多塞平膜控释制剂的制备方法,包括如下步骤:按处方量称取盐酸多塞平、二氧化硅、微晶纤维素乳糖复合物、喷雾干燥乳糖、微晶纤维素、硬脂酸镁,备用;置于万能粉碎机粉碎,然后加入多向混合机中混合;根据中间体的含量,计算片重,采用圆形浅凹模具压片;将片芯置于高效包衣锅中,开启包衣锅,控制包衣参数进行包衣,监测包衣增重,当包衣增重达到要求时,结束包衣,制得盐酸多塞平膜控释制剂。采用直压片工艺结合胃溶性膜衣,可以有效提高盐酸多塞平膜控释制剂的生物利用度和稳定性,且纯度更高。

Drugs covered by this patent

Patent Metadata

Patent number
CN110575444A
Jurisdiction
CN
Classification
Expires
2019-12-17
Drug substance claim
No
Drug product claim
No
Assignee
Suzhou Hong Sen Pharmaceutical Ltd By Share Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.